SB 284 Modifies the disciplinary authority of the Board of Pharmacy, defines the term legend drug for the purpose of certain pharmacy statutes, and grants exemption from sales tax for certain medical equipment and drugs
Sponsor: Wasson
LR Number: 1412S.05T Fiscal Note: 1412-05T.ORG
Committee: Financial and Governmental Organizations and Elections
Last Action: 7/11/2011 - Signed by Governor Journal Page:
Title: CCS HCS SB 284 Calendar Position: 16
Effective Date: Emergency Clause
House Handler: Sater

Full Bill Text | All Actions | Available Summaries | Senate Home Page | List of 2011 Senate Bills

Current Bill Summary

CCS/HCS/SB 284 - This act modifies the exemption from state and local sales tax for certain medical supplies, to include rentals of medical oxygen, home respiratory equipment and accessories, hospital beds and accessories, ambulatory aids, wheelchairs, scooters, reading machines, electronic print enlargers, electronic communication devices, and items used to modify motor vehicles for individuals with disabilities. The act also creates a sales tax exemption for drugs that are required to meet the Food and Drug Administration's over-the-counter drug labeling requirements.

This act allows the Board of Pharmacy to refuse to issue a certificate of registration, permit, or license to an applicant for a pharmacy or drug distributor license if the designated pharmacist-in-charge, manager-in-charge, or any officer, owner, manager, or controlling shareholder of the applicant has committed an act that would be grounds for discipline under the Board of Pharmacy's disciplinary statute.

This act defines the term "legend drug" for the purpose of certain pharmacy laws. Legend drugs will mean any drug or biological product that is subject to a certain federal law, is required to be labeled in certain ways, or is required to be dispensed by prescription only or is restricted to use by practitioners only. The act excludes certain drugs and drug products that are being used in clinical trials.

This act has an emergency clause for the section regarding legend drugs.

Provisions of this act are similar to HCS/SB 325 (2011), HB 55 (2011), and SCS/HCS/HB 412 (2011).